FDA Should Curb DTC Ads To Save Reputation – Former FDAer
This article was originally published in The Tan Sheet
Executive Summary
Pharmaceutical companies should work with FDA to tone down direct-to-consumer advertising, which is now considered a "visible concern," according to a former FDA official